Milner Institute delivers Cambridge-Google AlphaFold Workshop
We were delighted to welcome over 120 delegates in Cambridge last week, for a Cambridge-Google Workshop: Learning from Experts in Computational Biology and AI. The event was jointly organised by the Milner Therapeutics Institute, Cambridge AI Club for Biomedicine, and...
Milner Institute highlights in-house research capabilities at Cambridge Festival
The Milner Institute was delighted to take part in two Cambridge Festival events again this year. Held each spring, the Festival features a mix of online, on-demand, and in-person events, showcasing the groundbreaking research taking place across Cambridge. On 22...
Milner Institute hosts official opening of new Functional Genomics Screening Laboratory
Last week, we were delighted to launch the new Functional Genomics Screening Laboratory (FGSL) here at the Milner Therapeutics Institute in Cambridge, UK. The new lab will support world-class research and innovation in the rapidly advancing field of functional...
Milner Therapeutics Consortium renewed for five years
We are delighted that the Milner Therapeutics Consortium has been renewed until 2029, which will continue to provide opportunities for our academic and business communities to engage with pharma at an early stage. The Milner Therapeutics Consortium has been active...